Cancer News and Research

RSS
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
IL-2's flexible structure helping the immune system

IL-2's flexible structure helping the immune system

New CRISPR technology targets thousands of genes

New CRISPR technology targets thousands of genes

Researchers capture occurrence of bursts of diversity in microbiota in real time

Researchers capture occurrence of bursts of diversity in microbiota in real time

Study explains “dark” portion of human genome implicated in various disorders

Study explains “dark” portion of human genome implicated in various disorders

Research on mice shows unexpected effect of intermittent fasting on fat metabolism

Research on mice shows unexpected effect of intermittent fasting on fat metabolism

Copper-binding protein influences migration of breast cancer cells

Copper-binding protein influences migration of breast cancer cells

In a first, AI discovers antibiotic that kills dangerous bacteria

In a first, AI discovers antibiotic that kills dangerous bacteria

New discovery reveals earliest known instance of complex form of protein regulation

New discovery reveals earliest known instance of complex form of protein regulation

A new breakthrough could lead to better approaches for preventing breast cancer metastasis

A new breakthrough could lead to better approaches for preventing breast cancer metastasis

New method has revealed how cells communicate

New method has revealed how cells communicate

WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

Intact Protein Mass Spectrometry of Cell Culture Harvest Guides Cell Line Development for Trispecific Antibodies

Intact Protein Mass Spectrometry of Cell Culture Harvest Guides Cell Line Development for Trispecific Antibodies

Mass Spectrometry‐Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization

Mass Spectrometry‐Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization

Combining AIMS with machine learning to speed up breast cancer diagnosis

Combining AIMS with machine learning to speed up breast cancer diagnosis

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

Applying integrated lipidomics and proteomics in multiple myeloma reveals potential disease pathways

Considering evolution of the cancer genome in metastatic disease

Considering evolution of the cancer genome in metastatic disease

A new study finds a potential immunotherapeutic pan-target on cancer cells

A new study finds a potential immunotherapeutic pan-target on cancer cells

Clinical lipidomics in understanding of lung cancer: Opportunity and challenge

Clinical lipidomics in understanding of lung cancer: Opportunity and challenge

Lipidomics of human adipose tissue reveals diversity between body areas

Lipidomics of human adipose tissue reveals diversity between body areas

Risk assessments of mushroom consumption should factor in cooking and digestion

Risk assessments of mushroom consumption should factor in cooking and digestion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.